Dr. Reddy’s Laboratories Ltd.'s Q3 FY08 Revenue at Rs 12,320 Million; EBITDA at Rs 2,037 Million

January 25, 2008 |

1 min read

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced its unaudited financial results for the third quarter ended December 31, 2007.

Earnings Asia

MORE ON THIS TOPIC

Podcast

Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More

July 9, 2025

·

1 min read

·

Heather McKenzie

People are attracted to a profitable business. Corporation, joint venture. Fundraising. Fair distribution of income among team members. Development of funds, budget use. Investment groups. Corruption

Radiopharmaceuticals

Actithera Raises $75.5M To Play in Sizzling Radiopharma Space

July 9, 2025

·

2 min read

·

Tristan Manalac

Solution Concept with Handshake on Chalkboard Background

Mergers & acquisitions

Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout

July 8, 2025

·

1 min read

·

Annalee Armstrong

Robot and human hand in retro collage style with halftone. Vector illustration, artificial intelligence concept.

Artificial intelligence

Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero

July 7, 2025

·

2 min read

·

Dan Samorodnitsky